You are here: Industry Insights > drug discovery

News List

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen prnasia
November 10, 2020
Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, announced that it entered into a multi-target drug discovery agreement with Janssen ...
Axxam and Fujifilm Cellular Dynamics Enter Alliance contractpharma
October 10, 2020
Axxam S.p.A. and Fujifilm Cellular Dynamics Inc. announced a strategic alliance to improve the drug discovery process.
Nvidia partners with GSK’s AI lab for drug discovery pharmaceutical-technology
October 10, 2020
US-based chipmaker Nvidia has entered into a partnership with GlaxoSmithKline (GSK) and its artificial intelligence (AI) group for the discovery of drugs and vaccines.
Monte Rosa Therapeutics raises Series B funds for drug development pharmaceutical-technology
September 27, 2020
Monte Rosa Therapeutics has raised $96m in a Series B funding round to develop its drug pipeline.
Cambridge spin-out PharmEnable raises £1.8m for drug discovery pharmatimes
July 01, 2020
Cambridge spin-out PharmEnable has closed a £1.8-million seed financing to support its transition into a drug development company.
WuXi AppTec to expedite early drug discovery biospectrumasia
September 04, 2019
Launches DNA Encoded Library (DEL) Service Package "DELight"
Insilico Medicine uses AI to transform drug discovery biospectrumasia
September 03, 2019
Invention and scientific validation of GENTRL, an AI-powered system capable of creating new molecules in 21 days.
Pathfinder Research and Training Foundation organises summer training on drug discovery expresspharma
July 18, 2019
Pathfinder Research and Training Foundation (PRTF), in collaboration with Sharda University, recently conducted a month-long summer training which aimed at imparting basic skills to ...
Servier Australia, BioCurate to accelerate drug discovery biospectrumasia
July 17, 2019
To collaborate and accelerate discoveries of new therapeutics and drugs
Amgen and University of Washington partner on biotech drug discovery pharmaceutical-technology
June 21, 2019
Amgen has signed a strategic research partnership with the University of Washington’s Institute for Protein Design (IPD) that will apply IPD’s de novo protein design expertise to biotech drug discovery.

Previous page 1 2 3 4 5 6 7 8 Next page